Fulgent Genetics (FLGT) Other financing activities (2016 - 2026)

Fulgent Genetics (FLGT) has 9 years of Other financing activities data on file, last reported at $4.2 million in Q1 2026.

• Quarterly Other financing activities rose 122.58% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 72.33% YoY) and the FY2025 annual result came in at $3.0 million, up 4.73% from the prior year.
• Other financing activities rose to $4.2 million in Q1 2026 per FLGT's latest filing, from $447000.0 in the prior quarter.
• The five-year high for Other financing activities was $4.2 million in Q1 2026, with the low at $232000.0 in Q2 2023.
• Average Other financing activities over 5 years is $860882.4, with a median of $494000.0 recorded in 2022.
• The widest YoY moves for Other financing activities: up 1017.95% in 2022, down 92.38% in 2022.
• Fulgent Genetics' Other financing activities stood at $316000.0 in 2022, then jumped by 252.53% to $1.1 million in 2023, then tumbled by 78.28% to $242000.0 in 2024, then jumped by 84.71% to $447000.0 in 2025, then surged by 839.6% to $4.2 million in 2026.
• Business Quant data shows FLGT's Other financing activities at $4.2 million in Q1 2026, $447000.0 in Q4 2025, and $357000.0 in Q3 2025.